Investor Glaxosmithkline Plc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Glaxosmithkline Plc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-13 13D CVAC / CureVac N.V. 16,591,937 16,591,937
2025-03-28 13D/A SPRO / Spero Therapeutics, Inc. 9,190,606 9,190,606
2024-11-15 13D/A MEHCQ / 23andMe Holding Co. 39,660,487 1,983,025
2024-11-12 13G/A WVE / Wave Life Sciences Ltd. 13,983,761 16,775,691
2024-03-28 13D/A NKTX / Nkarta, Inc. 3,150,732 3,150,732
2024-02-09 13D/A HLN / Haleon plc - Depositary Receipt (Common Stock) 39,660,487
2024-02-06 13G/A WVE / Wave Life Sciences Ltd. 10,683,761 13,983,761
2024-02-06 13G/A CVAC / CureVac N.V. 16,591,937
2024-01-19 13D/A HLN / Haleon plc - Depositary Receipt (Common Stock) 385,320,110
2023-10-10 13D/A HLN / Haleon plc - Depositary Receipt (Common Stock) 738,132,722
2023-09-11 13D/A HLN / Haleon plc - Depositary Receipt (Common Stock) 1,008,132,722 1,008,132,722
2023-07-20 13D/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,529,561 1,529,561
2023-05-16 13D/A HLN / Haleon plc - Depositary Receipt (Common Stock) 1,008,132,722
2023-02-06 13G CVRX / CVRx, Inc. 1,007,583 1,007,583
2023-01-30 13G WVE / Wave Life Sciences Ltd. 10,683,761
2023-01-20 13D/A SPRO / Spero Therapeutics, Inc. 9,190,606 9,190,606
2023-01-20 13D/A ME / 23andMe Holding Co. 39,660,487 39,660,487
2022-11-14 13D/A SPRO / Spero Therapeutics, Inc. 1,740,606 9,190,606
2022-11-04 13D ME / 23andMe Holding Co. 39,660,487
2022-09-20 13D/A TBPH / Theravance Biopharma, Inc. 9,644,807 0
2022-08-03 13D/A TBPH / Theravance Biopharma, Inc. 9,644,807 9,644,807
2022-07-27 13D HLN / Haleon plc - Depositary Receipt (Common Stock) 1,195,320,110
2022-05-13 13D/A NKTX / Nkarta, Inc. 3,150,732 3,150,732
2022-02-10 13G/A GNCA / Genocea Biosciences Inc 5,217,389 5,861,389
2022-02-10 13G/A FSTX / F-star Therapeutics Inc 803,922 802,627
2022-02-10 13G LYEL / Lyell Immunopharma, Inc. 30,253,189
2022-02-10 13D/A TBPH / Theravance Biopharma, Inc. 9,644,807 9,644,807
2022-02-10 13G/A VIR / Vir Biotechnology, Inc. 6,626,027 8,550,954
2021-09-27 13G/A FULC / Fulcrum Therapeutics, Inc. 1,785,714 1,785,714
2021-09-16 13D/A SPRO / Spero Therapeutics, Inc. 1,740,606 1,740,606
2021-09-16 13D/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,616,295 1,529,561
2021-07-12 13G CVRX / CVRx, Inc. 1,007,583
2021-05-25 13D/A INVA / Innoviva, Inc. 32,005,260 0
2021-04-16 13D/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,894,831 1,616,295
2021-04-08 13D/A / Pandion Therapeutics Inc 2,262,301 0
2021-02-12 13D/A INVA / Innoviva, Inc. 32,005,260 32,005,260
2021-02-12 13G/A GNCA / Genocea Biosciences Inc 3,676,767 5,217,389
2021-02-12 13G/A PGNY / Progyny, Inc. 10,526,957 2,926,957
2020-12-07 13D/A SPRO / Spero Therapeutics, Inc. 1,819,478 1,740,606
2020-12-07 13D/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,915,275 1,894,831
2020-11-30 13G FSTX / F-star Therapeutics Inc 803,922
2020-11-06 13D/A TPTX / Turning Point Therapeutics Inc 2,268,660 2,273,618
2020-10-01 13D/A US74257L1089 / Principia Biopharma Inc. 3,042,193 0
2020-08-24 13G CVAC / CureVac N.V. 14,935,721
2020-08-03 13D / Pandion Therapeutics Inc 2,262,301 2,262,301
2020-07-31 13D / Pandion Therapeutics Inc 2,262,301
2020-07-22 13D NKTX / Nkarta, Inc. 3,150,732
2020-07-10 13D/A CRSP / CRISPR Therapeutics AG 3,295,627 3,310,627
2020-06-30 13D/A MORF / Morphic Holding, Inc. 1,431,551 1,431,551
2020-06-29 13D/A MORF / Morphic Holding, Inc. 1,533,772 1,431,551
2020-06-22 13D/A TBPH / Theravance Biopharma, Inc. 9,644,807 9,644,807
2020-06-17 13D/A TBPH / Theravance Biopharma, Inc. 9,644,808 9,644,807
2020-06-04 13D/A SPRO / Spero Therapeutics, Inc. 1,819,478
2020-05-26 13D/A TPTX / Turning Point Therapeutics Inc 1,992,550 2,268,660
2020-05-04 13G VIR / Vir Biotechnology, Inc. 6,626,027
2020-02-28 13G/A GNCA / Genocea Biosciences Inc 3,676,767 3,676,767
2020-02-27 13D/A TBPH / Theravance Biopharma, Inc. 9,644,808 9,644,808
2020-02-18 13D/A MORF / Morphic Holding, Inc. 2,633,772 1,533,772
2020-02-18 13D/A TBPH / Theravance Biopharma, Inc. 9,644,808 9,644,808
2020-02-14 13D/A SPRO / Spero Therapeutics, Inc. 1,934,006
2020-02-14 13D/A AGTC / Applied Genetic Technologies Corp 1,436,448 0
2020-02-14 13D/A ALRN / Rein Therapeutics Inc. 1,431,519 504,926
2020-02-14 13G/A GNCA / Genocea Biosciences Inc 14,557,004 3,676,767
2020-02-14 13G/A CNCE / Concert Pharmaceuticals Inc 1,179,941 1,179,941
2020-02-14 13D/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,915,275 1,915,275
2020-02-14 13G PGNY / Progyny, Inc. 10,526,957
2020-02-14 13D/A US74257L1089 / Principia Biopharma Inc. 2,654,336 3,042,193
2020-02-14 13G FULC / Fulcrum Therapeutics, Inc. 1,785,714
2020-02-14 13D/A CRSP / CRISPR Therapeutics AG 3,265,627 3,295,627
2019-07-25 13D/A MORF / Morphic Holding, Inc. 2,633,772 2,633,772
2019-07-12 13D MORF / Morphic Holding, Inc. 2,633,772
2019-06-07 13D BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,915,275
2019-05-10 13G ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock) 12,455,252
2019-04-26 13D TPTX / Turning Point Therapeutics Inc 1,992,550
2019-04-18 13D/A TBPH / Theravance Biopharma, Inc. 9,644,807 9,644,808
2019-02-25 13G GNCA / Genocea Biosciences Inc 2,121,668 14,557,004
2018-10-18 13D/A CCXI / ChemoCentryx Inc 7,343,492 0
2018-09-26 13D US74257L1089 / Principia Biopharma Inc. 2,654,336 2,654,336
2018-09-25 13D US74257L1089 / Principia Biopharma Inc. 2,654,336
2018-09-19 13D/A SPRO / Spero Therapeutics, Inc. 1,934,006
2018-09-18 13D/A CCXI / ChemoCentryx Inc 7,343,492 7,343,492
2018-07-17 13D/A SPRO / Spero Therapeutics, Inc. 1,934,006
2018-04-10 13D/A INVA / Innoviva, Inc. 32,005,260 32,005,260
2018-02-13 13G/A CNCE / Concert Pharmaceuticals Inc 1,179,941
2018-02-13 13D/A HTGM / HTG Molecular Diagnostics Inc 792,781 792,781
2018-02-13 13D/A GNCA / Genocea Biosciences Inc 2,121,668 2,121,668
2018-02-13 13D/A CRSP / CRISPR Therapeutics AG 3,250,627 3,265,627
2017-11-16 13D SPRO / Spero Therapeutics, Inc. 1,854,006
2017-09-01 13D/A HTGM / HTG Molecular Diagnostics Inc 792,781 792,781
2017-08-31 13D/A HTGM / HTG Molecular Diagnostics Inc 792,781 792,781
2017-07-20 13D/A HTGM / HTG Molecular Diagnostics Inc 792,781 792,781
2017-07-11 13D/A ALRN / Rein Therapeutics Inc. 1,431,519
2017-07-10 13D ALRN / Rein Therapeutics Inc. 1,431,519
2017-04-13 13D/A INVA / Innoviva, Inc. 32,005,260 32,005,260
2017-03-29 13D/A HTGM / HTG Molecular Diagnostics Inc 1,092,781 792,781
2017-02-03 13D/A TBPH / Theravance Biopharma, Inc. 9,644,807 9,644,807
2016-11-07 13D/A CRSP / CRISPR Therapeutics AG 3,250,627 3,250,627
2016-10-28 13D CRSP / CRISPR Therapeutics AG 3,250,627
2016-08-25 13D/A INVA / Innoviva, Inc. 32,005,260
2016-08-25 13D/A INVA / Innoviva, Inc. 32,005,260
2016-08-25 13D/A CCXI / ChemoCentryx Inc 7,343,492
2016-05-13 13D/A TBPH / Theravance Biopharma, Inc. 9,644,807 9,644,807
2016-03-24 13D TBPH / Theravance Biopharma, Inc. 8,343,792 9,644,807
2016-02-09 13G/A SCYX / SCYNEXIS, Inc. 545,006
2016-02-09 13G/A TBPH / Theravance Biopharma, Inc. 8,299,218 8,343,792
2016-02-09 13G/A DDXS / Diadexus, Inc. 244,233
2015-09-02 13G TBPH / Theravance Biopharma, Inc. 8,299,218
2015-08-14 13D/A 032420101 / Anacor Pharmaceuticals, Inc. 2,171,374
2015-08-03 13D/A GNCA / Genocea Biosciences Inc 1,971,668 2,121,668
2015-05-15 13D HTGM / HTG Molecular Diagnostics Inc 1,092,781
2015-03-17 13D/A GNCA / Genocea Biosciences Inc 1,971,668
2015-02-24 13D/A AGTC / Applied Genetic Technologies Corp 1,436,448
2015-02-13 13D/A AGTC / Applied Genetic Technologies Corp 1,939,598
2015-02-13 13G CNCE / Concert Pharmaceuticals Inc 1,356,533
2015-02-13 13D/A 032420101 / Anacor Pharmaceuticals, Inc. 2,771,374
2015-02-13 13G/A RGLS / Regulus Therapeutics Inc. 1,476,203
2014-11-04 13D/A INVA / Innoviva, Inc. 31,581,179
2014-10-28 13G/A FOLD / Amicus Therapeutics, Inc. 0
2014-05-15 13G SCYX / SCYNEXIS, Inc. 545,009
2014-04-07 13D AGTC / Applied Genetic Technologies Corp 1,989,598
2014-02-25 13G/A US670CCR9934 / Nupathe Inc. 0
2014-02-14 13G/A FOLD / Amicus Therapeutics, Inc. 11,315,825
2014-02-14 13G OMED / OptMed Inc 2,607,546
2014-02-14 13G/A US670CCR9934 / Nupathe Inc. 4,183,652
2014-02-14 13D GNCA / Genocea Biosciences Inc 1,671,667
2014-02-14 13G/A RGLS / Regulus Therapeutics Inc. 3,360,467
2013-08-01 13D/A INVA / Innoviva, Inc. 29,785,600
2013-07-11 13D/A KDUS / Cadus Corp. 0
2013-05-01 13D/A CCXI / ChemoCentryx Inc 7,343,492
2013-03-01 13D/A 032420101 / Anacor Pharmaceuticals, Inc. 2,771,374
2013-02-12 13G/A US670CCR9934 / Nupathe Inc. 4,166,846
2012-12-19 13G XNPT / XenoPort, Inc. 4,031,212
2012-10-10 13G RGLS / Regulus Therapeutics Inc. 3,303,775
2012-09-21 13G RGDXQ / Response Genetics, Inc 5,000,000
2012-07-17 13G/A FOLD / Amicus Therapeutics, Inc. 9,815,825
2012-05-16 13D/A INVA / Innoviva, Inc. 25,814,421
2012-04-06 13G/A FOLD / Amicus Therapeutics, Inc. 6,866,244
2012-04-02 13D/A INVA / Innoviva, Inc. 15,814,421
2012-02-23 13D CCXI / ChemoCentryx Inc 7,343,492
2012-02-13 13G/A US670CCR9934 / Nupathe Inc. 1,166,846